EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance

Zhan Zhang iD, Bangye Chen, Yanchen Liu, Kai Zhang, Zihao Wei, Yunlu Dai iD, Caigang Liu

ACS Nano · 02.09.2025 · 19 (34) · 30720-30757

DOI: 10.1021/acsnano.5c02321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 21.08.2025. Verfasst von Zhan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Nanomedicine, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 425 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Liaoning Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsNanomedicineDrug Resistance, NeoplasmAntineoplastic AgentsNeoplasmsHumansAnimalsTumor MicroenvironmentDrug Delivery Systems

Stichwörter der Autor:innen

CSC markersbiomaterialbiomedical engineeringcancer stem celldrug deliverynanomedicineprecision oncologytherapeutic resistancetumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
  • Cancer Stem Cell and Translational Medicine Laboratory, Shengjing Hospital of China Medical University, Shenyang 110022, China.
  • Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shenyang 110022, China.
  • Department of Gastroenterology, Endoscopic Center, Shengjing Hospital of China Medical University, Shenyang 110022, China.
  • Cancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, China.
  • MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR 999078, China.

ORCID-Profile: Zhan Zhang, Yunlu Dai

Förderung

  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Liaoning Province
  • National Natural Science Foundation of China
  • Shenyang U35 Youth Top-notch Talent Project

Zitieren

APA

Zhang, Z., Chen, B., Liu, Y., Zhang, K., Wei, Z., Dai, Y., & Liu, C. (2025). Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance. ACS Nano, 19(34), 30720-30757. https://doi.org/10.1021/acsnano.5c02321

Vancouver

Zhang Z, Chen B, Liu Y, Zhang K, Wei Z, Dai Y, et al. Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance. ACS Nano. 2025;19(34):30720-30757. doi:10.1021/acsnano.5c02321

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhan and Chen, Bangye and Liu, Yanchen and Zhang, Kai and Wei, Zihao and Dai, Yunlu and Liu, Caigang},
  title = {Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {34},
  pages = {30720--30757},
  doi = {10.1021/acsnano.5c02321}
}
Kostenlos starten →